Metabolic syndrome (MetS) is a condition of abdominal diseases
characterised by insulin resistance, obesity, atherogenic dyslipidaemia, hypertension,
and hypercoagulability and is a serious risk factor for the development of
cardiovascular diseases (CVD) and type II diabetes mellitus (T2DM) [1]. The outbreak
of SARS-CoV-2 infection has been named Coronavirus Disease 2019 (COVID-19) by
the World Health Organisation (WHO). MetS is emerging as a significant risk factor
for worse outcomes in people with COVID-19. Metabolic diseases, especially chronic
diseases related to diabetes, lead to heart disease and some neurodegenerative diseases
in old age. With SARS-CoV-2, researchers all over the world have investigated the
relationship between metabolic diseases and the virus. In fact, COVID-19 management
is not different from the management of patients with severe and serious diabetes and
the management of other critical illnesses. In the mortality and morbidity of COVID19, the presence of comorbid diseases, especially diabetes (hypertension, obesity,
diseases and drugs affecting the immune system, cardiovascular diseases, etc.) and
advanced age are determinants. It has also been shown that patients with poor
metabolic health are more susceptible to complications such as seizures, strokes, and
encephalitis during COVID-19 due to factors accompanying previous illness. Chronic
diseases are diseases that progress slowly, last three months or longer, are caused by
more than one risk factor, usually show a complicated course, and affect the quality of
life of the person. The end of COVID-19 as a global health emergency does not mean
'the end of COVID-19 as a global health threat'. The threat of different COVID-19
variants emerging that could cause new increases in morbidity and mortality remains.
Monitoring and management of chronic diseases will not only positively change the
course of COVID-19 but will also make it possible to use the limited resources in the
health sector in the right way.
Keywords: COVID-19, Comorbid diseases, Chronic diseases, Diabetes mellitus, Hypertension, Metabolic syndrome, Obesity.
